Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push - Reuters
Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxOX0g4M0x4Zk1xRGRkS2ktTmo0SEJKZ3dSc2NWQzk2Zm83TkVTODZHaGVsdmtocHBJMEdaQTZKX3pTVnA1a0pweHBlZDZPVWJTWDMyM0l0OTROcnJFdGhCMURwUUtvQlh3OVBwRHQyZjd6cmJxVk1qdE9NUkVMeDY4S2JZQWtFMVc3NGlNbFM3T0s3dHZBVmxWeXdzN05OSUFvZ2xCYQ?oc=5" target="_blank">Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Canada's Weston family to buy UK's Boots in $8.9 billion deal - Reuters
Canada's Weston family to buy UK's Boots in $8.9 billion deal Reuters
October 7, 2026 at 04:53 PMMcKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal - Reuters
McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal Reuters
October 6, 2026 at 04:30 PMMcKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports - Reuters
McKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports Reuters
October 5, 2026 at 09:09 PMIntesa's MPS bid set to redraw Italian banking landscape - Reuters
Intesa's MPS bid set to redraw Italian banking landscape Reuters
October 5, 2026 at 06:19 PMGate Bioscience expands Lilly drug discovery deal worth more than $870 million - Reuters
Gate Bioscience expands Lilly drug discovery deal worth more than $870 million Reuters
October 5, 2026 at 01:55 PMAlector soars as Roche licenses Parkinson's therapy for up to $1.27 billion - Reuters
Alector soars as Roche licenses Parkinson's therapy for up to $1.27 billion Reuters
October 5, 2026 at 12:15 PM